Chikungunya is a rare viral infection transmitted by the bite of the infectedaedes aegypti mosquito, occurring primarily in tropical areas of Africa as well as South and Southeast Asia. Symptoms include high fever, joint and muscular pain, severe headaches, body aches and a rash similar to that seen in dengue patients.
- Occurs after monsoon rains
- Rarely fatal
While the flu-like fever is painful, lasting from a few days to a couple of weeks, the U.S. Centers for Disease Control and Prevention (CDC) says no deaths from chikungunya have been conclusively proven in scientific literature.
Source: http://alertnet.org/db/crisisprofiles/MU_CHI.htm
From Wikipedia, the free encyclopedia
Treatment
There are no specific treatments for Chikungunya. There is no vaccine currently available. A Phase II vaccine trial, sponsored by the US Government and published in the American Journal of Tropical Medicine and Hygiene in 2000, used a live, attenuated virus, developing viral resistance in 98% of those tested after 28 days and 85% still showed resistance after one year.[10]
A serological test for Chikungunya is available from the University of Malaya in Kuala Lumpur, Malaysia.
Chloroquine is gaining ground as a possible treatment for the symptoms associated with chikungunya, and as an anti-inflammatory agent to combat the arthritis associated with Chikungunya virus. A University of Malaya study found that for arthritis-like symptoms that are not relieved by aspirin and non-steroidal anti-inflammatory drugs (NSAID), chloroquinephosphate (250 mg/day) has given promising results.[11] Research by an Italian scientist, Andrea Savarino, and his colleagues together with a French government press release in March 2006[12] have added more credence to the claim that chloroquine might be effective in treating chikungunya. Unpublished studies in cell culture and monkeys show no effect of chloroquine treatment on reduction of chikungunya disease. The fact sheet on Chikungunya advises against using aspirin, ibuprofen, naproxen and other NSAIDs that are recommended for arthritic pain and fever.
.
.
Prognosis
 |
This section requires expansion. |
Recovery from the disease varies by age. Younger patients recover within 5 to 15 days; middle-aged patients recover in 1 to 2.5 months. Recovery is longer for the elderly. The severity of the disease as well as its duration is less in younger patients and pregnant women. In pregnant women, no untoward effects are noticed after the infection.
Ocular inflammation from Chikungunya may present as iridocyclitis, and have retinal lesions as well.[14]
Pedal oedema (swelling of legs) is observed in many patients, the cause of which remains obscure as it is not related to any cardiovascular, renal or hepatic abnormalities.
.
.
.
Oh well. Nothing too serious luh lol. John kena.
YANN are discussing. 
Sheena, 
si bin, and 1 other are discussing. 
“he wrote better strokes than I am”
you are one of the strokes meh?
hahas. its, he wrote better strokes than I can.
HAHHAHA huna ur a stroke, or some strokes.